Radio and PodcastLive Radio & PodcastsScience & Medicine
105 - Neurodegenerative Disease Recap! ALXO and LGVN updates plus Breaking Breaking 2021 Top Trades
ALXO announces new HR-MDS data that disappoints! I talk about the comparison to Magrolimab data and why I think ALXO is still a buy. LGVN pushes data updates but is still a risk for a short squeeze! I talk about some of...
About This Episode
105 - Neurodegenerative Disease Recap! ALXO and LGVN updates plus Breaking Breaking 2021 Top Trades is an episode from Breaking Biotech by Matthew Lepoire. ALXO announces new HR-MDS data that disappoints! I talk about the comparison to Magr...
Podcast
This episode belongs to Breaking Biotech.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jan 3, 2022, 00:41:29 long, audio available.
Related Episodes
Continue listening to more episodes from Breaking Biotech.
112 - Biotech Updates - $BTAI $TGTX $CRIS $CKPT $KPTI $SRRA
Apr 21, 2022 - 00:43:59
111 - Achieve Life Sciences Phase 3 Readout Imminent! Interview with CEO John Bencich
Apr 1, 2022 - 00:28:19
109 - Karyopharm Guides INCREASED Sales Growth in 2022 and Reports Positive SIENDO Results
Feb 22, 2022 - 00:33:42
108 - NASH Companies to Watch in 2022! Madrigal Pharma Announces Positive Data in NAFLD
Feb 7, 2022 - 00:37:28
106 - Bright Spot Among CRISPR in Caribou Biosci. 2022 Biotech Trends to Watch!
Jan 9, 2022 - 00:42:53